MedPath

Analysis of survival impact of lymphadenectomy in endometrial cancer patients received adjuvant chemotherapy at intermediate/high risk of progression.

Not Applicable
Conditions
Endometrial cancer
Registration Number
JPRN-UMIN000046209
Lead Sponsor
Japanese Gynecologic Oncology Group
Brief Summary

Although it was difficult to assess the therapeutic significance of PAN dissection in the JGOG 2043 cohort, thorough PLN dissection was shown to improve pelvic control and OS.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Female
Target Recruitment
788
Inclusion Criteria

Not provided

Exclusion Criteria

Patient without registration of the number of resected lymph node

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relapse-free survival
Secondary Outcome Measures
NameTimeMethod
Overall survival
© Copyright 2025. All Rights Reserved by MedPath